On the contrary, the relative values of each of the three MRS-measurable metabolites were significantly higher in the CSF of PTEN-mutant GBM patients compared to that of PTEN-wildtype GBM patients (with the exception of lactate, which follows a similar trend) (Fig. 7D and 7F). This evidence concerns the gene PTEN and glioblastoma.